The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif
Nature Medicine2003Vol. 9(11), pp. 1404–1407
Citations Over TimeTop 1% of 2003 papers
Related Papers
- → APOBEC3F Can Inhibit the Accumulation of HIV-1 Reverse Transcription Products in the Absence of Hypermutation(2006)303 cited
- → Quantification of Deaminase Activity-Dependent and -Independent Restriction of HIV-1 Replication Mediated by APOBEC3F and APOBEC3G through Experimental-Mathematical Investigation(2014)38 cited
- → APOBEC3G & HTLV-1: Inhibition without deamination(2005)34 cited
- → Structure and real-time monitoring of the enzymatic reaction of APOBEC3G which is involved in anti-HIV activity(2009)11 cited
- → HIV Restriction Factor APOBEC3G and Prospects for Its Use in Gene Therapy for HIV(2022)